greeksoup/ stock research

Medtronic (MDT) FY2023 results: revenue $31.2 billion, down 1.4% on the year

Medtronic plc (MDT) reported revenue of $31.2 billion for fiscal 2023, the year ended 28 April 2023, down 1.4% on the year before. Net income was $3.8 billion, down 25.4%, and diluted earnings per share $2.82. The figures are the company's own, from the 10-K it filed with the SEC on 22 June 2023.

Revenue
$31.2 billion
-1.4% on the year
FY2016FY2023
Operating margin
17.6%
18.2% a year earlier
FY2016FY2023
Net income
$3.8 billion
-25.4% on the year
FY2016FY2023
Diluted EPS
$2.82
-24.4% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue31,22731,68630,117-1.4%
Cost of revenue10,71910,14510,483+5.7%
Gross profit20,50821,54119,634-4.8%
Gross margin65.7%68.0%65.2%
Research and development2,6962,7462,493-1.8%
Selling, general and administrative10,41510,29210,148+1.2%
Operating income5,4855,7524,484-4.6%
Operating margin17.6%18.2%14.9%
Interest expense636553925+15.0%
Pre-tax income5,3645,5173,895-2.8%
Income tax1,580456265+246.5%
Effective tax rate29.5%8.3%6.8%
Net income3,7585,0393,606-25.4%
Net margin12.0%15.9%12.0%
Diluted EPS$2.82$3.73$2.66-24.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow6,0397,3466,240-17.8%
Capital expenditure1,4591,3681,355+6.7%
Free cash flow4,5805,9784,885-23.4%
Free cash flow margin14.7%18.9%16.2%
Cash from investing-3,493-1,659-2,866
Cash from financing-4,960-5,336-4,136
Depreciation and amortisation2,6972,7072,702-0.4%
Share-based compensation355359344-1.1%
Buybacks6452,544652-74.6%
Dividends paid3,6163,3833,120+6.9%
Dividend per share$2.72$2.52$2.32+7.9%
Diluted shares, weighted1,333m1,351m1,354m-1.4%
Shares outstanding at period end1,331m1,331m1,345m+0.0%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity51,48352,55151,428-2.0%
Non-controlling interest182171174+6.4%
Debt24,34424,11426,378+1.0%
Operating lease liabilities869703829+23.6%
Finance lease liabilities57.056.062.0+1.8%
Other liabilities14,01313,38614,212+4.7%
Total liabilities and equity90,94890,98193,083-0.0%
Fixed assets5,5695,4135,221+2.9%
Goodwill41,42540,50241,961+2.3%
Intangible assets14,84415,59517,740-4.8%
Investments6,4166,8597,224-6.5%
Cash and equivalents1,5433,7143,593-58.5%
Receivables5,9985,5515,462+8.1%
Inventory5,2934,6164,313+14.7%
Other assets9,8608,7317,569+12.9%
Total assets90,94890,98193,083-0.0%

10-K for the year ended 28 April 2023, filed 22 June 2023: the filing.